Theolytics
Transforming patients’ lives | Through world leading science | With a great team
31 employees · est. 2017 · Oxford, United Kingdom
Vyriad
Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes directly to cells.
51 employees · est. 2015 · Rochester, United States
Vyriad is the older company (2017 vs 2015); Vyriad is the larger of the two.
Side-by-Side Comparison
| Metric | Theolytics | Vyriad |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2015 older |
| Headquarters | ||
| Headquarters | Oxford, United Kingdom | Rochester, United States |
| Employees | ||
| Employees | 31 | 51 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series B |
| Total Funding | ||
| Total Funding | $50.40M | $88.38M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Viral Platforms, Manufacturing of Genetic Therapies, Preclinical and Clinical Trial Management, Collaborative Research and Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Medical Institutions, Pharmaceutical Companies, Research Organizations, Healthcare Organizations |
| Taxonomy | ||
| Taxonomy | Oncolytic Viral Therapy, Phenotypic Screening Platform, Cancer Treatment, Adenoviral Therapy, Clinical Stage Biotechnology, Pipeline Development, Solid Tumors, Liquid Tumors, Virology, Partnerships, Intravenous Delivery, Patient Population, Disease Combat, Science Innovation | Biotech, Genetic Therapies, Oncolytic Virotherapy, Viral Vectors, Gene Editing, Cancer Treatment, Phase 1-2 Clinical Studies, Targeted Cell Therapy, Immuno-Oncology, Clinical Research Collaboration, Proprietary Oncolytic Virus, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Squamous Cell Carcinoma |
| Website | ||
| Website | theolytics.com | vyriad.com |
About Theolytics
Theolytics, a biotechnology company based in the United Kingdom, is dedicated to transforming patients’ lives through world-leading science and a great team. Founded in 2017, Theolytics is at the forefront of oncolytic viral therapy, harnessing viruses to combat cancer. The company's phenotypic scre...
About Vyriad
Vyriad, a United States-based clinical-stage biotech company, is making strides in the biotechnology sector by pioneering targeted genetic therapies. These therapies are designed to deliver genes directly to cells using engineered viruses, viral vectors, and envelope glycoproteins. The company's tec...
We will tell you when either one moves
BounceWatch watches Theolytics and Vyriad for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Theolytics and Vyriad — by email.
Frequently Asked Questions
Compare Theolytics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Theolytics on 11 Sep 2024, and Vyriad on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.